Attached files
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002
In
connection with the Quarterly Report of Pharma-Bio Serv, Inc. (the
"Company") on Form 10-Q for the period ending April 30, 2021 as
filed with the Securities and Exchange Commission on the date
hereof (the "Report"), Victor Sanchez, Chief Executive Officer of
the Company, and Pedro J. Lasanta, Chief Financial
Officer of the Company, each certify, pursuant to 18
U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to my knowledge:
1. The
Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended;
and
2. The
information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations
of the Company.
Dated:
June 14, 2021
/s/
Victor Sanchez
|
|
/s/
Pedro J. Lasanta
|
Victor
Sanchez
|
|
Pedro
J. Lasanta
|
Chief
Executive Officer
(principal
executive officer)
|
|
Chief
Financial Officer
(principal
financial and accounting officer)
|